Summary Human ovarian carcinoma cells obtained from ascites were tested for susceptibility to lysis by peripheral blood NK cells, alpha-interferon-activated NK cells, and interleukin 2-activated killer cells. Cryopreserved tumour cell preparations were used to allow repeated testing of the same target, and the tumour cells were fractionated using albumin density gradients to determine if fractions containing clonogenic (stem) cells were killed. Four tumour cell donors were studied and each showed a different pattern of susceptibility of unfractionated tumour to lysis by different effector cells. Using fractionated tumour cells, we found that NK and interferon-activated NK cells did not always lyse cells in the clonogenic fractions and that interferon activation could in some cases shift killing away from the clonogenic fractions and towards the peak of proliferating (but not self-renewing) colony forming cells. Interleukin 2-activated killer cells (LAK) however, killed the fractions containing clonogenic cells in all 4 cases. The magnitude of killing seen when fractions of the original tumour were tested was often striking when compared to lysis of the unfractionated cells. Apparent heterogeneity between patients and stem cell susceptibility to effector cells may be important determinants of the efficacy of treatment of patients with biologic response modifiers such as interferon and interleukin 2.
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Non-specific cytotoxic cells of various types have been proposed to exert significant anti-tumour effects in vivo. (Hersey et al., 1982; Pross & Rubin, 1982; Vanky et al., 1984; Jacubovich et al., 1985; Rola-Pleszczynski et al., 1985) . Not uncommonly, such inferences have been based on the demonstration of killing of tumour target cells in vitro (Pross & Rubin, 1982) . Target cells for these studies have usually been cultured cell lines. However, 'real' tumours in vivo consists of heterogeneous collections of cells some of which are stem cells, some proliferating and differentiating cells, and many sterile non-dividing end cells (Buick, 1984; Mackillop & Buick, 1981) . Cultured cell lines derived from the same tumour may differ among each other and differ from their precursor cells in the original tumour. For example, it is known that cell culture may produce alterations in chromosome number and may lead to increased sensitivity to lysis by natural killer (NK) cells present in human peripheral blood (Shau et al., 1983) . In contrast, the cells of the original tumour when freshly isolated are usually resistant to lysis (Shau et al., 1983; Vanky et al., 1984) . Alterations in susceptibility to lysis are likely due to either culture-induced changes in cell phenotype or to selection of a minor subpopulation whose killing by NK cells is inapparent when diluted by a large number of NK-resistant cells. We have recently suggested, for example, that expression of CEA by tumour cells may correlate with NK susceptibility (Clark et al., 1984) . Not all cells in a CEA-positive tumour express CEA, and in the case of ovarian carcinoma, only cells at an early stage of differentiation appear to express the antigen (Buick et al., 1983) . Therefore, it was particularly important to determine if stem cells might be killed by NK cells. Recently it has become apparent that freshly isolated NKresistant tumour cells may be efficiently lysed by interleukin-2 activated lymphocytes (LAK) (Grimm et al., 1982) . It was therefore of additional interest to determine if susceptibility to LAK might include the stem cell population.
Using colony assays, cell surface markers, and density gradient separations it has been possible to separate and identify different cellular elements in fresh uncultured ovarian carcinoma ascites (Mackillop & Buick, 1981; Buick et 1983). The colony-forming and self-renewing colony forming cells (putative stem cells) have been assigned to specific subpopulations (Mackillop & Buick, 1981 
Materials and methods

Target cells
Procurement of ascites from ovarian carcinoma patients has been described previously. Twelve of 250 patients provided at least 108 cells with less than 5% non-tumour cells in single cell suspension, and these were frozen in aliquots in 10% DMSO (Mackillop & Buick, 1981; Buick et al., 1983; Buick, 1984) . Aliquots were thawed for use and separated using albumin density gradients as previously described (Mackillop & Buick, 1981) . The reproducibility of our gradients based on the peak of the cell distribution profile was +1 density step.
Effector cells for cytotoxic assays
Lymphocytes were routinely isolated from heparinized venous blood provided by one of the authors, using hypaque ficoll (density 1.077). The PBL were used fresh as a source of endogenous NK cell activity, or after a 0.5-1 h incubation at 37"C with 100 units ml-1 recombinant alpha-interferon (kindly provided by Hoffman-LaRoche). LAKs were obtained by culturing PBL at 5 x 106 ml-1 in RPMI 1640 with 10% foetal bovine serum, 100 iu ml-1 penicillin G, 100l g ml-' streptomycin (Grand Island Biol. Co., Grand a)
The mean and s.e.m. from 4-6 replicates was determined.
Colony assay
The ability of unfractionated tumour cells to form colonies was determined as described elsewhere (Mackillop & Buick, 1981; Buick, 1984) . Briefly, OW tumour cells which retained colony forming ability after freezing were thawed and plated in methylcellulose; the triplicate dishes were incubated for 1-3 weeks, and colonies of 64 or more cells counted. These larger colonies have been shown to correlate with the presence of colony forming cell self-renewal (Buick, 1984) . In some experiments, the tumour cells were incubated overnight at 37°C with PBL or LAK in 50ml plastic centrifuge tubes (Falcon) prior to plating. NK and LAK effector cells were irradiated (2.5Gy 137Cs) to prevent proliferation and possible colony formation, and an aliquot of the effector cells was added to the methylcellulose plus untreated tumour cells to test for an effect on colony formation independent of contact occurring during the overnight preincubation.
Statistics
The significance of differences was assessed using Student's t test.
Results
The susceptibility of unseparated ovarian tumour cells to lysis by different effector cell types is shown in two peaks. The peak on the left correlated with the peak of proliferating colony -forming cells, as described previously (Mackillop & Buick, 1981 [5] [6] [7] (data not shown). Figure lb shows the result obtained with a second patient (SA). Again, two peaks of killing by PBL NK activity were seen. Interferon activation boosted lysis, but interestingly, the right hand peak that should be associated with stem cells was significantly attenuated whereas the left hand peak associated with the proliferative cell peak was enhanced. LAK, in contrast, showed a broad distribution of cytotoxicity that associated with the right hand peak and was active in those fractions expected to contain stem cells. Figure 2 shows a third patient (BA). In Figure 2a one can again see the two peaks of killing with PBL-NK, and as with patient SA, interferon activation boosted the left hand peak and attenuated the right hand peak. LAK activity ( Figure  2b) reproducibly showed 3 peaks of activity, with substantial activity against fractions that were not particularly susceptible to activated NK cells. The same pattern of killing was reproduced using interferon and IL-2 activated PBL from a second normal donor. Figure 3a shows a fourth patient (OW). The individual fractions of the tumour were quite resistant to killing. Figure  3b shows that some fractions could be killed above 10% by interferon activated NK cells and 2-3 peaks of activity could be discerned. In contrast, LAK produced substantial lysis, including those fractions expected to contain stem cells.
Although LAK appeared to kill fractions expected to contain stem cells, the lysis of stem-cell enriched fractions was seldom > 50% and since the frequency of stem cells has been estimated to be less than 1/50, (Mackillop & Buick, 1981) it was quite possible that stem cells were not being killed by LAK. It was possible to directly test whether or not stem cells were killed by LAK using the OW cell line that has retained its ability to form colonies in spite of liquid nitrogen storage. OW tumour cells (Figure 3 ) that were sensitive to LAK but resistant to NK cell killing were incubated with effector cells at a ratio of 25-100:1 in plastic tubes overnight at 37°C as described in Materials and methods and then were plated in methylcellulose. The presence of irradiated PBL (or LAK) prevented from contacting the targets enhanced colony formation. In contrast, direct contact with LAK markedly reduced colony formation to levels below the medium only control (Table II) . These data were compatible with the thesis that colony forming cells were killed. Indeed, these colonies were smaller in size, consistent with killing of self-renewing cells. (Buick, 1984; Clark et al., 1984) .
A second point that may be drawn from the data is that killing by NK and interferon-activated NK cells often 'spared' those fractions expected to contain the bulk of the self-renewing stem cell population. Indeed, interferon activation could increase net killing, but shift the spectrum of cytotoxicity away from the stem cell-containing fractions! LAK proved more cytotoxic to the fractions expected to contain stem cells and preliminary data using the OW cell line indicated colony forming cells were killed.
A third point that can be drawn from the data is illustrated by tumours such as BA and SA that showed little if any killing of unseparated tumour cells but quite respectable killing of particular fractions of separated tumour. Indeed, the lack of lysis of unseparated tumour would not have been expected from the curves shown in Figure lb and Figure 2 . There are two possible interpretations of these data. First, it is possible that density gradient fractionation separated and concentrated susceptible and resistant target cells (Roozemond et al., 1986) . The probability of a susceptible target being lysed is proportional to the probability of an encounter with an effector cell, and this in turn is determined by the concentration of targets and effectors. The frequency of susceptible targets might be 1/3 in a particular fraction but only 1/30 in whole tumour. Therefore, significant lysis of unseparated tumour cells might be missed. Second, it is possible that lysis of susceptible targets was suppressed by other cells present in the unseparated tumour.
Suppression of cytolytic effectors by suppressor cell activity in tumour has required preincubation with effector cells prior to testing on target cells Uchida & Micksche, 1982; Haskill et al., 1982) . Only alveolar macrophages have been shown to inhibit killing by NK cells when added directly to the assay itself (Bordignon et al., 1982) . However, in other systems, cells exist that can directly inhibit killing by cytolytic effector cells. A subpopulation of cells in the placenta can block target killing by NK, ADCC, LAK, and CTL (Clark & Chaouat, 1986) . Host macrophages have been implicated as suppressor cells in preincubation assays, but it should also be noted that Whiteside et al. (1986) have indicated tumour cells may also render unresponsive potential effector lymphocytes within a tumour. In the context of tumours, it may not be the host's lymphomyeloid cells that are suppressive but rather the tumour cells themselves (Vose & Moore, 1979) . Preliminary experiments done recently in our laboratory suggest that unseparated ovarian carcinoma cells can suppress lysis of susceptible subpopulations by interferon activated NK cells. The nature of this inhibition and whether it can account for variation in susceptibility of different fractions of the tumour is currently being examined.
On the basis of the data in this paper, one may speculate that it will be important to know the sensitivity pattern of tumour subpopulations for each patient when biological response modifiers are being used and to know if there are inhibitors in the tumour that might inactivate the relevant effector cells. However, one must stress that the data in this paper have been obtained using effector cells that are allogeneic. For most of the studies, a single donor was used in order to keep one unknown in the system (ie the effector cells) constant while the second unknown (ie the source of the tumour cells) was varied. Now that we have evidence for differences between patient's tumours, the next step will be to study autochthonous cell activity using the patient's own effector cells. Unfortunately, such studies could not be done using our frozen stored tumour cell stock used in the study described in this paper because no PBL had been stored at the time the patients were alive.
